Clinical trial
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
NCT00002757 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002757 |
|---|---|
| Title | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma |
| Official title | FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Societe Francaise Oncologie Pediatrique Children's Cancer and Leukaemia Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, methotrexate, prednisolone, prednisone, therapeutic hydrocortisone, vincristine sulfate |
| Enrollment | 1,148 |
| Start date | Jun 1, 2001 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 24, 2014 |
| Countries | France, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: